AstraZeneca Plc has made a preliminary approach to rival drugmaker Gilead Sciences Inc about a potential merger, according to people familiar with the matter, in what would be the biggest health-care deal on record.
The UK-based firm informally contacted Gilead last month to gauge its interest in a possible tie-up, the people said, asking not to be identified because the details are private.
